CN1247204C - Medicine for treating beri-beri - Google Patents
Medicine for treating beri-beri Download PDFInfo
- Publication number
- CN1247204C CN1247204C CN 200410033696 CN200410033696A CN1247204C CN 1247204 C CN1247204 C CN 1247204C CN 200410033696 CN200410033696 CN 200410033696 CN 200410033696 A CN200410033696 A CN 200410033696A CN 1247204 C CN1247204 C CN 1247204C
- Authority
- CN
- China
- Prior art keywords
- medicine
- present
- kilograms
- fast
- griseofulvin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention discloses medicine for treating beriberi. The present invention is composed of calamine, borneol, realgar, sulfur, calomelas, arsenolite, chlorphenamine, diphenhydramine griseofulvin and vitamin B1. Clinical application results indicate that the medicine of the present invention has the advantages of short course of treatment, fast effect taking and high cure rate, can fast act on focus, and has the functions of preventing mycotic infection, preventing bacteria, relieving inflammation, dispelling wind, eliminating dampness, expelling toxin, removing necrotic tissue, promoting tissue regeneration, nourishing skin, fast relieving itching, etc. The present invention has the characteristics of simple preparation method, low price and easy popularization application.
Description
Technical field
The present invention relates to a kind of medicine, especially relate to a kind of medicine for the treatment of beriberi.
Background technology
Beriberi, be tinea pedis again, be a kind of by fungus-caused, scratching where it itches with toe is a kind of infectious dermatosis of primary symptom, the main medicine for external use that adopts agent, unguentum or powder in the treatment is as daktarin, Compound Flavescent Sophora and Salicylic Acid Powder etc., though these medicines have certain curative effect, but clinical these medicines that show take effect slowly, and cure rate is not high.
Summary of the invention
The object of the present invention is to provide a kind of instant effect, the medicine of the treatment beriberi that cure rate is high.
Purpose solution of the present invention is on the basis to the cause of disease of beriberi, pathology understanding, according to inventor's clinical practice for many years, processes through the screening compatibility.
Medicine of the present invention is made up of Calamina, Borneolum Syntheticum, Realgar, sulfur, Calomelas, Arsenicum sablimatum, chlorphenamine, diphenhydramine, griseofulvin and vitamin B1.
Medicine of the present invention can be by the weight portion proportioning preparation of Calamina 40-80, Borneolum Syntheticum 10-30, Realgar 10-30, sulfur 10-30, Calomelas 10-30, Arsenicum sablimatum 5-20, chlorphenamine 60-100, diphenhydramine 30-70, griseofulvin 10-30 and vitamin B1 80-120.
The preferred prescription of medicine of the present invention is: the weight portion proportioning preparation of pressing Calamina 50-70, Borneolum Syntheticum 15-25, Realgar 15--25, sulfur 15-25, Calomelas 15-25, Arsenicum sablimatum 8-16, chlorphenamine 70-85, diphenhydramine 40-60, griseofulvin 15-25 and vitamin B1 90-110.
The prescription of medicine the best of the present invention is: the weight portion proportioning preparation of pressing Calamina 60, Borneolum Syntheticum 20, Realgar 20, sulfur 20, Calomelas 20, Arsenicum sablimatum 10, chlorphenamine 80, diphenhydramine 50, griseofulvin 20 and vitamin B1 100.
The method that above-mentioned each component is made medicine of the present invention is: above-mentioned each component drug pulverize separately is become fine powder, mix in proportion, can obtain the powder of this medicine.The carrier vaseline mixing and stirring that powder and medicine is commonly used can be made unguentum.
Administrated method: with medicine directly be applied in affected part before the sleep every day.Unguentum directly uses, and powder need be mixed well use with vaseline oil or skin Kang Shuan ointment etc.
Clinical drug of the present invention uses the result to show that following advantage is arranged: 1, short treating period, instant effect, this medicine very fastoperation have the inhibition fungal infection in affected area, and anti-inflammation, expelling wind and removing dampness, toxin expelling corruption, granulation promoting are repaiied skin, effect such as antipruritic fast.2, through 196 routine Preliminary Clinical Observation, cure rate is up to 90%, and effective percentage reaches more than 98%, and is without any side effects.3, preparation method is simple, and is cheap, is easy to promote the use of.
The specific embodiment
Embodiment 1: with preparation double centner medicated powder is example, 25 kilograms of 15 kilograms of Calaminas, 5 kilograms of Borneolum Syntheticums, 5 kilograms of Realgars, 5 kilograms of sulfurs, 5 kilograms of Calomelass, 2.5 kilograms of Arsenicum sablimatum, 20 kilograms of chlorphenamines, 12.5 kilograms of diphenhydramine, 5 kilograms of griseofulvin and vitamin B1s.Above-mentioned each component drug pulverize separately is become 100 order fine powders, and mix homogeneously, process are sterilized, and can obtain the powder of this medicine.
Embodiment 2: to prepare 200 kilograms of ointment is example, 2.5 kilograms of 17.5 kilograms of Calaminas, 5 kilograms of Borneolum Syntheticums, 5 kilograms of Realgars, 5 kilograms of sulfurs, 5 kilograms of Calomelass, 3 kilograms of Arsenicum sablimatum, 21 kilograms of chlorphenamines, 10 kilograms of diphenhydramine, 6 kilograms of griseofulvin and vitamin B1ies.Become 100 order fine powders and double centner vaseline mix homogeneously, process to sterilize above-mentioned each component drug pulverize separately, can obtain the unguentum of this medicine.
Claims (3)
1, a kind of medicine for the treatment of beriberi is characterized in that what it was made up of following components in weight portions: Calamina 40-80, Borneolum Syntheticum 10-30, Realgar 10-30, sulfur 10-30, Calomelas 10-30, Arsenicum sablimatum 5-20, chlorphenamine 60-100, diphenhydramine 30-70, griseofulvin 10-30 and vitamin B1 80-120.
2, the medicine of treatment beriberi according to claim 1, wherein the weight portion proportioning of each component is: Calamina 50-70, Borneolum Syntheticum 15-25, Realgar 15-25, sulfur 15-25, Calomelas 15-25, Arsenicum sablimatum 8-16, chlorphenamine 70-85, diphenhydramine 40-60, griseofulvin 15-25 and vitamin B1 90-110.
3, the medicine of treatment beriberi according to claim 2, wherein the weight portion proportioning of each component is: Calamina 60, Borneolum Syntheticum 20, Realgar 20, sulfur 20, Calomelas 20, Arsenicum sablimatum 10, chlorphenamine 80, diphenhydramine 50, griseofulvin 20 and vitamin B1 100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410033696 CN1247204C (en) | 2004-04-19 | 2004-04-19 | Medicine for treating beri-beri |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410033696 CN1247204C (en) | 2004-04-19 | 2004-04-19 | Medicine for treating beri-beri |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562078A CN1562078A (en) | 2005-01-12 |
| CN1247204C true CN1247204C (en) | 2006-03-29 |
Family
ID=34481376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410033696 Expired - Fee Related CN1247204C (en) | 2004-04-19 | 2004-04-19 | Medicine for treating beri-beri |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1247204C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103005782A (en) * | 2012-11-27 | 2013-04-03 | 王加庆 | Anti-microbial insoles |
| CN104147045A (en) * | 2014-08-12 | 2014-11-19 | 朱金凤 | Plaster for effective treatment of foot ulcer |
-
2004
- 2004-04-19 CN CN 200410033696 patent/CN1247204C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1562078A (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793785B (en) | Chinese rhubarb-baical skullcap root-amur corktree bark itching-relieving liniment and preparation method thereof | |
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| CN102258609B (en) | Sanhuang antipruritic liniment and its preparation method | |
| CN100569273C (en) | A kind of external Chinese medicine that is used for the treatment of skin tumour, tinea, wart, herpes | |
| CN1939522A (en) | Externally-applied medicinal composition for treating dermatosis and its making method | |
| Samarh et al. | Evidence based medical use of aloe vera extracts, short review of literature | |
| CN1247204C (en) | Medicine for treating beri-beri | |
| CN1943581A (en) | External use medicine for treating dermatosis and its preparing method | |
| CN1224406C (en) | Medical ointment Jiaoxuanxiao for treating beriberi | |
| CN1078396A (en) | Medicine for treating dermatosis and manufacture method thereof | |
| CN1772048A (en) | Medicine oil for relaxing joints and its prepn | |
| CN100563683C (en) | A kind of external preparation for the treatment of skin amyloidosis | |
| CN103751491A (en) | Medicament for treating dermatophytosis, psoriasis, dermatitis and flat wart, and treating method | |
| CN1090961C (en) | Process for preparing onychomycosis ointment | |
| CN102415953B (en) | Deodorizing medicinal cosmetic and preparation method thereof | |
| CN105726564A (en) | Ointment for treating skin tinea | |
| CN1090936C (en) | Compound preparation for curing acne | |
| CN1843366A (en) | Burn-treating liquid | |
| CN1989993A (en) | Effective alopecia-preventing liniment | |
| CN1182852C (en) | Medicine for curing dermatosis | |
| CN1301727C (en) | Externally applied Chinese medicine preparation for treating skin disease and its preparation method | |
| CN100536866C (en) | Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin | |
| CN1712009A (en) | Externally-applied medicinal liquid for treating acne, rosacea and folliculitis | |
| CN1297294C (en) | Extemal remedy for treating eczema | |
| CN1951440A (en) | Chinese medicinal lotion prescription for treating psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060329 Termination date: 20110419 |